Stage Group | Febrile Neutropenia | Invasive Bacterial | Oral Herpes Simplex Infection | Mucositis Grade III/IV | Parenteral Opioid Analgesic | TPN | PICU Admission | Reduction of Chemotherapy | |
Stage I | Count % within Risk Group % of Total | 0
0.0% 0.0% | 0
0.0% 0.0% | 0
0.0% 0.0% | 0
0.0% 0.0% | 0
0.0% 0.0% | 0
0.0% 0.0% | 0
0.0% 0.0% | 0
0.0% 0.0% |
Stage II | Count % within stage Group % of Total | 5
83.3% 17.9% % | 2
33.3% 7.1% | 1
16.7% 3.6% | 3
50.0% 10.7% | 3
50.0% 10.7% | 2
33.3% 7.1% | 0
0.0% 0.0% | 0
0.0% 0.0% |
Stage III | Count % within stage Group % of Total | 9
81.8% 32.1% | 3
27.3% 10.7% | 2
18.2% 7.1% | 5
45.5% 17.9% | 4
36.4% 14.3% | 3
27.3% 10.7% | 2
18.2% 7.1% | 3
27.3% 10.7% |
Stage IV | Count % within stage Group % of Total | 9
90.0% 32.1% | 4
40.0% 14.3% | 3
30.0% 10.7% | 6
60.0% 21.4% | 6
60.0% 21.4% | 4
40.0% 14.3% | 6
60.0% 21.4% | 1
10.0% 3.6% |
Total | Count % of Total | 23 (82.1%) | 9 32.1% | 6 21.4% | 14 50.0% | 13 46.4% | 9 32.1% | 8 28.6% | 4 14.3% |